RAYMOND JAMES & ASSOCIATES - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 168 filers reported holding CARDLYTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$310,000
+52.7%
2,444
+71.5%
0.00%
Q4 2020$203,000
-78.4%
1,425
-89.3%
0.00%
-100.0%
Q3 2020$940,000
+147.4%
13,318
+145.6%
0.00%0.0%
Q2 2020$380,000
+56.4%
5,423
-22.0%
0.00%
Q1 2020$243,000
-63.5%
6,955
-34.2%
0.00%
-100.0%
Q4 2019$665,000
-37.4%
10,574
-83.5%
0.00%
-50.0%
Q1 2019$1,062,000
+82.2%
64,186
+19.3%
0.00%
+100.0%
Q4 2018$583,000
+65.2%
53,800
+281.6%
0.00%0.0%
Q3 2018$353,00014,1000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 4,488,972$640,891,00035.51%
Antipodean Advisors LLC 656,000$93,657,00026.30%
KPS Global Asset Management UK Ltd 1,021,830$145,887,00021.39%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 302,700$43,216,00017.58%
Oakcliff Capital Partners, LP 269,895$38,533,00015.30%
Alua Capital Management LP 920,259$131,385,0009.19%
Covey Capital Advisors, LLC 47,736$6,815,0005.95%
EVR Research LP 50,000$7,139,0005.83%
683 Capital Management, LLC 659,997$94,228,0004.46%
Hidden Lake Asset Management LP 72,900$10,408,0004.08%
View complete list of CARDLYTICS INC shareholders